Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2174-2021Class II

Kaguya Automated Peritoneal Dialysis System

Baxter Healthcare Corporation / initiated 2021-06-30 / Terminated

BAXTER HEALTHCARE CORPORATION began a recall of Kaguya Automated Peritoneal Dialysis System on . FDA classified it as Class II and gives the reason as "Baxter Healthcare Corporation has identified that the AMIA Sharesource User Guide that is used with the AMIA Automated PD System cyclers incorrectly describes the function of the UF (Ultrafiltration) Limit setting as...". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2174-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Baxter Healthcare Corporation
Product
Kaguya Automated Peritoneal Dialysis System
Product code
FKX System, Peritoneal, Automatic Delivery
Reason for recall
Baxter Healthcare Corporation has identified that the AMIA Sharesource User Guide that is used with the AMIA Automated PD System cyclers incorrectly describes the function of the UF (Ultrafiltration) Limit setting as the ending criteria of the cyclers Extra Last Drain Mode. In some locations in the guide, it states that the UF volume achieved must exceed the programmed UF Limit before the cycler will end the Extra Last Drain, allowing the patient to end therapy or proceed to their last fill.
FDA root cause
Under Investigation by firm
Action
The firm notified its consignees by letter on 06/30/2021. The letter explained the issue with the instructions for use, specifically, That the AMIA Sharesource User Guide describes the function of the UF (ultrafiltration) Limit setting as the ending criteria of the cycler's Extra Last Drain Mode. Baxter will be sending a Follow-Up communication once the AMIA Sharesource User Guide has been updated on the portal.
Quantity in commerce
5101 units
Distribution
Worldwide distribution - US Nationwide distribution and the country of Japan.
Product codes and lots
Product Code T5C8500 (distribution in Japan only)

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2174-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2173-2021Class IITerminatedVoluntary: Firm initiated
Z-2174-2021Class IITerminatedVoluntary: Firm initiated